Cardiology Perspective

 
 
  • The Year in Neurology 2018   New studies in 2018: Dr Hans-Christoph Diener discusses recent results from studies across neurology that have led to practice changes.
  • Smartphone Post-op Photos: Proceed With Caution Dr Lowenfels comments on a study that evaluated whether patient-generated photographs improve a surgeon's ability to remotely determine the likelihood of a wound complication.
  • Eric Topol's Top Advances in 2018 That Are Shaping Medicine Which advances in 2018 have the most potential to transform medicine? Dr Eric Topol shares his insights.
  • Dec 21 2018 This Week in Cardiology   Dr John Mandrola discusses upcoding for PCI, hypertension, a pacing lead issue, a PAD trial discovery, and an FDA warning on fluoroquinolones in this week’s podcast.
  • 'Interesting Research' in Pediatric Cardiology: AHA 2018   Dr Andrew Glatz discusses important research on pediatric CPR and prenatal diagnosis of congenital heart disease presented at AHA 2018.
  • ARBs/ACEIs After AKI: Balancing Tradeoffs Dr Bansal reviews a study that provides important data on the use of RAAS inhibitors after acute kidney injury--an understudied clinical topic.
  • Malpractice Case: When 'Normal' Test Results Get You Into Trouble Sometimes after a bad result, the only error a physician makes is trying to do too much without a specialist's assistance.
  • The Top Cardiology Trials of 2018 in Review Contrasting studies on the benefits of percutaneous mitral valve repair and a fall from grace for aspirin make the list for Bob Harrington and Mike Gibson. Find out what else piqued their interest.
  • Dual vs Triple Antithrombotic Therapy? The Debate Continues   Is a NOAC plus an antiplatelet drug enough to prevent thromboses? Stroke? What doses and combinations are safest? Christian Ruff, Mike Gibson, and Chris Cannon examine the evidence.
  • Advice for Anyone Contemplating Locum Tenens Work After quitting full-time practice, Melissa Walton-Shirley, MD, joined the ranks of medical temp workers. Here's her advice on getting started.
  • Mandrola's Top 10 Cardiology Stories of 2018 From blood pressure management in the community to a study on potentially biased referees -- John Mandrola reviews his picks for the year's big stories in cardiology and medicine.
  • What It Takes to Be a Top 10 Stroke Hospital Dr Andrew Wilner on how physician surveys of top hospitals provide models of success worth emulating.
  • Most Memorable Gifts Received From Patients It's the holidays, and that means 'thank you' gifts from patients for your care. Here are some notable presents received by physicians.
  • Dec 14 2018 This Week in Cardiology   Carotid stents, more stem-cell retractions, AHA statement on statin safety, flu vaccine rules, medication errors, veterans care, and wasteful NIH research on golfing are discussed in this week’s podcast.
  • Do Neprilysin Inhibitors Have a Role in Patients With CKD? Dr Desai reviews the UK HARP-III trial, which compares the effects of sacubitril/valsartan and irbesartan on kidney function in people with CKD.
  • Cardiovascular Outcomes Trials Give 'Comforting' Results   Dr Anne Peters gives us her take on the recent CARMELINA, DECLARE-TIMI, and REWIND trials and their cardiovascular outcomes.
  • Does PIONEER-HF Warrant Acute HF Indication for ARNI?   Drs Pina and Butler discuss the new findings of PIONEER-HF, a trial evaluating angiotensin-neprilysin inhibition in acute heart failure.
  • Dec 7 2018 This Week in Cardiology   Measures of hospital quality, statin under- or over-use, Botox for AF, smoking cessation and translating trial evidence to clinical practice are discussed in this week’s podcast.
  • What Do You Think About Retirement?   Is it healthier to retire or keep working? The answer may surprise you.
  • SGLT2 Inhibitors: Is This the Start of a New Era? Gregory Nichols discusses exciting new clinical trial results demonstrating the benefits of SGLT2 inhibitors, as presented at the AHA 2018 Scientific Sessions.